Smith Nancy Freda
SEC insider (Form 3/4/5 filer). CIK 0002019811. Director at Tempest Therapeutics, Inc. (TPST) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 22, 2026. Located in MAHWAH, NJ.
Companies Smith Nancy Freda has filed insider reports for
- Tempest Therapeutics, Inc. (TPST): Director
- CHUY'S HOLDINGS, INC. (CHUY): Director
Smith Nancy Freda
CIK: 0002019811
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
